Interleukin-6 Antagonists [MoA] - N0000191004

Pharmacologic Class Information

Pharmacologic Code N0000191004
Pharmacologic Name Interleukin-6 Antagonists
Pharmacologic Uses
  • interleukin-6 (IL-6) antagonist
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Interleukin-6 Antagonists

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Interleukin-6 Antagonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
73090-420Sylvant Non-Proprietary Name: SiltuximabInjection, Powder, For SolutionIntravenousEusa Pharma (uk) LtdACTIVE
73090-421Sylvant Non-Proprietary Name: SiltuximabInjection, Powder, For SolutionIntravenousEusa Pharma (uk) LtdACTIVE